A case report. Osteogenesis imperfecta type III in an adult woman. Ten years of treatment with bisphosphonates. What now?
DOI:
https://doi.org/10.32818/reccmi.a2n2a6Keywords:
osteogenesis imperfecta, type III, bisphosphonates, zoledronic acidAbstract
The osteogenesis imperfecta (OI) is a hereditary disease that groups connective tissue disorders, which later cause fragility and bone deformities. Low bone mineral density and high incidence of bone pain and fractures require the application of antiresorptive targeted treatment, where bisphosphonates are the best treatment. We report the case of a 35-year-old female with type III OI who had been treated for ten years with intravenous zoledronic acid. This case allows for the revising of the treatments used to date.
Downloads
Metrics
References
Forlino A, Marini JC. Osteogenesis imperfecta. Lancet. 2016 Apr; 387(10028): 1657-71.
Sinikimpu JJ, Ojaniemi M, Lehenkari P, et al. Severe osteogenesis imperfecta Type-III and its challenging treatment in newborn and preschool children. A systematic review. Injury. 2015 Aug; 46(8): 1440-6.
Cheung MS, Glorieux FH. Osteogenesis Imperfecta: update on presentation and management. Rev Endocr Metab Disord. 2008 Jun; 9(2): 153-60.
Golshani KR, Ludwig MR, Cohn PL, et al. Osteogenesis Imperfecta. Del Med J. 2016 Jun; 88(6): 178-85.
Adami S, Gatti D, Colapietro F, et al. Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res. 2003; 18: 126.
Shapiro JR, Thompson CB, Wu Y, et al. Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta. Calcif Tissue Int. 2010; 87: 120.
Xu XJ, Ma DD, Lv F, et al. The clinical characteristics and efficacy of biphosphonates in adult patients with osteogenesis imperfecta. Endocr Pract 2016 Aug 2.
Orwoll ES, Shapiro J, Veith S, et al. Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J Clin Invest. 2014 Feb; 124(2): 491-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Carmen Pérez-Blanco, Isabel Pavón-de Paz, Cristina Navea-Aguilera, José Antonio Rosado-Sierra, Diego García-García
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
